GlassScriptPhysician profile
Adam P Schiff
NPI 1457515033
$806,344.88
in general payments reported to CMS, 2019-2025
14 companies · $150K in 2025
The $150K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $33K · 2021: $36K · 2022: $204K · 2023: $160K · 2024: $143K · 2025: $150K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $370K · Travel and Lodging: $43K · Royalty Or License: $36K · Food and Beverage: $5,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $369,973.66 |
| Travel and Lodging | $42,509.84 |
| Royalty Or License | $35,901.43 |
| Food and Beverage | $5,327.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $380,273.78 | 2019-2025 | Prophecy, Hoffmann, Prostep |
| Medshape, INC. | $241,707.79 | 2021-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Mini |
| Trilliant Surgical LLC. | $132,287.78 | 2021-2025 | Arsenal Sinus Support Plate, Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Ankle |
| Encore Medical, LP | $25,282.66 | 2021-2025 | |
| Ipsen Bioscience INC. | $9,965.76 | 2019 | |
| Surgalign Spine Technologies, INC. | $6,071.50 | 2019 | |
| Restor3d, INC. | $4,093.99 | 2021-2025 | |
| Novastep INC. | $4,049.26 | 2024-2025 | Nexis, Airlock Centrolock |
| New Standard Device, LLC Dba Metalogix | $1,000.00 | 2022 | |
| Rti Surgical, INC | $700.00 | 2021 | |
| Depuy Synthes Sales INC. | $533.10 | 2019-2024 | Na |
| Flower Orthopedics Coporation | $308.19 | 2023-2025 | |
| Wright Medical Technology, INC. | $45.83 | 2019 | |
| Djo, LLC | $25.24 | 2024 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,523.13 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.